Status:
RECRUITING
Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma
Lead Sponsor:
AI Labs Group S.L
Collaborating Sponsors:
Servicio Vasco de Salud Osakidetza, Spain
Osakidetza
Conditions:
Melanoma
Melanoma, Skin
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this Cross-sectional analytical observational study of clinical case series is to validate a Computer-aided diagnosis software developed by AI Labs Group for the identification of cutaneou...
Detailed Description
Introduction Cutaneous melanoma (CM), a type of skin cancer, has seen a significant rise in incidence and mortality. It\'s particularly aggressive and can metastasize rapidly, making it resistant ...
Eligibility Criteria
Inclusion
- Patients with skin lesions with suspected malignancy
- Age over 18 years old
- Patients who consent to participate in the study by signing the Informed Consent form
Exclusion
- Patients under 18 years of age
Key Trial Info
Start Date :
September 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06221397
Start Date
September 17 2020
End Date
September 1 2024
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Cruces
Barakaldo, Biscay, Spain, 48903